期刊文献+

血浆N-末端B型利钠肽原对ICU重症患者预后的预测价值 被引量:2

Value of plasma NT-pro-BNP in predicting the prognosis of critically ill patients in ICU
下载PDF
导出
摘要 目的探讨血浆N-末端B型利钠肽原(NT-proBNP)水平对ICU重症患者预后的预测价值。方法回顾2011年10月~2012年4月北京市仁和医院ICU收治的137例患者临床资料,患者入院即时行急性生理和慢性健康状况Ⅱ(APACHEⅡ)评分,并于入ICU第1天、第2天、第3天、第5天、第7天采用酶联免疫吸附法(ELISA)测定血浆NT-proBNP水平,计算患者28 d病死率,分析血浆NT-proBNP与APACHEⅡ对患者预后的预测价值。结果 137例患者28 d病死率为31.39%(43/137),94例存活(存活组),43例死亡(死亡组)。死亡组严重感染患者多,APACHEⅡ评分高(P<0.05)。存活组与死亡组血浆NT-proBNP水平均于入ICU第2天到达峰值;死亡组第2天、第3天、第5天和第7天血浆NT-proBNP水平均显著高于存活组(P<0.05)。多因素分析显示,NT-proBNP>1 565.2 ng/L及A-PACHEⅡ评分均可预测患者28 d病死率(P<0.05)。结论 NT-proBNP>1 565.2 ng/L及APACHEⅡ评分是ICU重症患者28 d病死率的独立预测因子,NT-proBNP>1 565.2 ng/L及APACHEⅡ评分越高,提示患者预后不良,可为临床诊断及指导治疗提供借鉴。 Objective To investigate the value of plasma N-terminal probrain natriuretic peptide(NT-pro-BNP) in predicting the prognosis of critically ill patients in ICU.Methods A total of 137 patients in ICU of Beijing Renhe Hospital from October 2011 to April 2012 were evaluated by using acute physiology and chronic health evaluation Ⅱ(APACHEⅡ),and the level of plasma NT-proBNP was determined on the first day,second day,third day,fifth day and seventh day after admitted into ICU by using ELISA,the 28-day mortality was calculated,then the values of plasma NT-proBNP and APACHEⅡ score in predicting the prognosis of patients were also analyzed.Results The 28-day mortality of patients was 31.39%(43/137),94 patients were survival(survival group) and 43 patients were non-survival(non-survival group).The patients in non-survival group were older than the survival group,suffered more severe infection,and had higher APACHE Ⅱ score than the survival group(P 0.05).Both survival group and non-survival group had the highest level of plasma NT-proBNP on the second day after admitted into ICU;the level of plasma NT-proBNP on the second day,third day,fifth day and seventh day after admitted into ICU of non-survival group were higher than those of survival group(P 0.05).Multiplicity analysis showed that,both the level of plasma NT-proBNP1 565.2 ng/L and APACHE Ⅱ score could predict the 28-day mortality(P 0.05).Conclusion The level of plasma NT-proBNP 1 565.2 ng/L and APACHE Ⅱ score are the independent predictive factors for the 28-day mortality of critically ill patients in ICU,NT-proBNP 1 565.2 ng/L and higher APACHE Ⅱ score indicate poor prognosis for critically ill patients,which can provide reference for the clinical diagnosis and guiding treatment.
作者 王婷 王敏
出处 《中国医药导报》 CAS 2012年第33期54-56,共3页 China Medical Herald
关键词 重症监护室 N-末端脑钠肽前体 预后 预测 ICU N-terminal probrain natriuretic peptide Prognosis Prediction
  • 相关文献

参考文献18

  • 1Kotanidou A ,Karsaliakos P,Tzanela M,et al. Prognostic importance of increased plasma amino-terminal pro-brain natriuretic peptide levels in a large noncardiac,general intensive care unit population [J]. Shock, 2009,31 (4) :342-347.
  • 2主有峰,韦建瑞.B型钠尿肽的临床意义及研究进展[J].国际医药卫生导报,2010,16(5):631-635. 被引量:4
  • 3Yasue H,Yoshimura M,Sumida H,et al. Localization and mechanism of secretion of B-type natriuretic peptide in comparison with those of A- type natriuretic peptide in normal subjects and patients with heart fail- ure [J]. Circulation, 1994,90 ( 1 ) : 195-203.
  • 4毛懿,杨跃进,张健,叶苓,赵冬云,倪新海,陈纪林,高润霖,陈在嘉.急性心肌梗死患者血B型利钠肽水平与心功能的相关性和诊断心力衰竭的价值[J].中华心血管病杂志,2009,37(3):218-222. 被引量:40
  • 5王卓然,周珂,邓勇.血清BNP水平与急性脑梗死亚型关系研究[J].医学研究杂志,2010,39(10):71-74. 被引量:20
  • 6Roch A,Allardet SJ,Michelet P,et al. NH2 terminal pro-brain natfiuret- ic peptide plasma level as an early marker of prognosis and cardiac dys- function in septic shock patients [J]. Crit Care Med,2005,33(6): 1001-1007.
  • 7《中国重症加强治疗病房(ICU)建设与管理指南》(2006)[J].中国危重病急救医学,2006,18(7):387-388. 被引量:184
  • 8Joe BH,Jo U,Kim HS,et al. APACHE II score,rather than cardiac function, may predict poor prognosis in patients with stress-induced car- diomyopathy [J]. J Korean Med Sci ,2012,27( 1 ):52-57.
  • 9Sabatine MS,Morrow DA,Delemos JA,et al. Acute changes in circulat- ing natriuretic peptide levels in relation to myocardial ischemia [J]. J Am Coil Cardio1,2004,44( 1 ) : 1988-1995.
  • 10Estrada JLN,Rubinstein F,Bahit MC,et al. NT-probrain natriuretic peptide predicts complexity and severity of the coronary lesions in pa- tients with non-ST-elevation acute syndromes [J]. Am Heart J, 2006,15 ( 15 ) : 1093-1097.

二级参考文献91

  • 1张春玲,康金锁,陈曦,张丽,张健,杨跃进,丛祥凤.心血管病患者血浆N端B型脑钠肽水平变化及其临床意义[J].中华检验医学杂志,2006,29(1):31-34. 被引量:38
  • 2各类脑血管疾病诊断要点[J].中华神经科杂志,1996,29(6):379-380. 被引量:33020
  • 3白梅,杨杰孚,李莹莹.氨基酸末端脑钠素前体与心房颤动的相关性研究[J].中华心律失常学杂志,2006,10(5):375-378. 被引量:2
  • 4Anand IS, Fisher LD, Chiang YT, et al. Changes in brain natriuretic peptide and norepinephrine over time and mortality and morbidity in the Valsartan Heart Failure Trial (VaI-HeFT). Circulation, 2003, 107 : 1278-1283.
  • 5Maurellet JD, Liu PT. B-type natriuretic peptide in the management of heart failure. Hong Kong Med J, 2008,14:216- 219.
  • 6Cowie MR, Mendez GF. BNP and congestive heart failure. Prog Cardiovasc Dis ,2002,44:293-321.
  • 7Omland T, Aakvaag A, Bonarjee VV, et al. Plasma brain natriuretic peptide as an indicator of left ventricular systolic function and long-term survival after acute myocardial infarction. Circulation, 1996,93 : 1963-1969.
  • 8Suzuki S, Yoshimura M, Nakayama M, et al. Plasma level of B- type natriuretic peptide as a prognostic marker after acute myocardial infarction: a long-term follow-up analysis. Circulation, 2004,110 : 1387-1391.
  • 9Crilley JG, Farrer M. Left ventricular remodeling and brain natriuretic peptide after first myocardial infarction. Heart, 2001, 86:638-642.
  • 10Deo R, de Lemos JA. B-type natriuretic peptide in ischemic heart disease. Curr Cardiol Rep,2003 ,5 :271-277.

共引文献587

同被引文献16

  • 1Rudiger A, Gasser S, Fischler M, et al. Comparable increase of B-type natriuretic peptide and amino-terminal pro-B-type natriuretic peptide levels in patients with severe sepsis, septic shock, and acute heart failure. Crit Care Med, 2006,34(8) :2140-2144.
  • 2Seino Y, Ogawa A, Yamashita T, et al. Application of NT-proBNP and BNP measurements in cardiac care: a more discerning marker for the detection and evaluation of heart failure. Eur J Heart Fail, 2004,6(3 ) :295-300.
  • 3Xia WJ, Huang YY, Chen YL, et al. Acute myocardial ischerrfia directly modulates the expression of brain natriuretie peptide at the transcriptional and translational levels via inflammatory cytokines. Eur J Pharmacol, 2011,670( 1 ) : 7-12.
  • 4Eisenhut M. A persistently elevated C-reactive protein level in pneumonia may indicate empyema. Crit Care, 2008,12( 1 ) :409.
  • 5Dilli D, Ouz SS, Dilmen U, et al. Predictive values of neutrophil CD64 expression compared with interleukin-6 and C-reactive protein in early diagnosis of neonatal sepsis. J Clin Lab Anal, 2010,24(6 ) : 363-370.
  • 6Almagor M, Keren A, Banal S. Increased C-reactive protein level after coronary stent implantation in patients with stable coronary artery disease. Am Heart J, 2003,145 (2) : 248-253.
  • 7Metheny NA, Clouse RE, Chang YH, et al. Tracheobronchial aspiration of gastric contents in critically ill tube-fed patients: frequency, outcomes, and risk factors. Crit Care Med, 2006,34 (4): 1007-1015,.
  • 8Kotanidou A, Karsaliakos P, Tzanela M, et al. Prognostic importance of increased plasma amino-terminal pro-brain natriuretic peptide levels in a large noncardiac, general intensive care unit population. Shock, 2009,31 (4) :342-347.
  • 9Phua J, Koay ES, Lee KH. Lactate, procalcitonin, and amino- terminal pro-B-type natriuretic peptide versus cytokine measurements and clinical severity scores for prognostication in septic shock. Shock, 2008,29(3 ) : 328-333.
  • 10Andreas M, Zeisler H, Handisurya A, et al. N-terminal-pro-brain natriuretic peptide is decreased in insulin dependent gestational dia- betes mellitus: a prospective cohort trial [ J ]. Cardiovasc Diabetol, 2011,10 ( 1 ) :28.

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部